卵巢癌患者新蝶呤生成与吲哚胺2,3-双加氧酶介导色氨酸分解的免疫生化通路与循环肿瘤细胞相关——OVCAD联盟研究
研究检测了良性妇科疾病患者(n=65)与原发性晚期上皮性卵巢癌患者诊断时(n=216)及辅助铂类化疗后六个月(n=45)血浆新蝶呤、色氨酸和犬尿氨酸水平,并与既往qPCR检测的循环肿瘤细胞(CTC)相关转录本进行关联分析。结果显示,上皮性卵巢癌中犬尿氨酸/色氨酸比值(Kyn/Trp)和新蝶呤升高与晚期疾病、腹膜癌病、腹水、减瘤不理想、治疗反应差及更差结局相关,且在CTC阳性患者中诊断时和铂敏感疾病随访时均升高。
要点
- 上皮性卵巢癌中Kyn/Trp和新蝶呤升高与晚期疾病、腹膜癌病、腹水、减瘤不理想、治疗反应差及更差结局相关。
- CTC阳性患者诊断时及铂敏感疾病随访时新蝶呤和Kyn/Trp均升高。
- CTC与免疫系统相关生物标志物同时改变,提示免疫反应及新蝶呤和Kyn/Trp升高可能不限于肿瘤局部,也可能在循环中持续存在。
核心结论
- 观察到CTC与免疫系统相关生物标志物同时改变,提示免疫反应伴随新蝶呤和Kyn/Trp浓度升高可能不限于肿瘤部位,也可能在循环中持续存在。
研究设计与样本
- 研究检测良性妇科疾病患者(n=65)与原发性晚期上皮性卵巢癌患者诊断时(n=216)及辅助铂类化疗后六个月(n=45)血浆新蝶呤、色氨酸和犬尿氨酸水平。
- 采用酶联免疫吸附试验和高效液相色谱法测定血浆水平,CTC存在与否基于既往研究通过qPCR分析血液中CTC相关转录本进行评估。
- 上皮性卵巢癌与良性样本血浆水平比较采用双尾卡方检验或Fisher精确检验,分析物及Kyn/Trp与临床病理参数、铂敏感性和CTC相关转录本的关联采用双侧t检验,与患者结局的关联采用Cox回归分析。
主要发现
- 上皮性卵巢癌中Kyn/Trp和新蝶呤升高与晚期疾病、腹膜癌病、腹水、减瘤不理想、治疗反应差及更差结局相关。
- CTC阳性患者诊断时及铂敏感疾病随访时新蝶呤和Kyn/Trp均升高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Circulating tumor cells (CTCs) may represent a chronic stimulus for the immune system. In the present study we investigated the potential association of CTCs, the immune activation marker neopterin, and the ratio of kynurenine to tryptophan (Kyn/Trp) as a measure for tryptophan breakdown. METHODS: Neopterin, tryptophan and kynurenine levels were measured in plasma samples from patients with benign gynecological diseases (n=65) and with primary advanced epithelial ovarian cancer (EOC) at diagnosis (n=216) and six months after adjuvant platinum-based chemotherapy (n=45) by an enzyme-linked immunosorbent assay and high performance liquid chromatography. The presence of CTCs had been assessed in a previous study by qPCR-based analysis of CTC-related transcripts in the blood. The respective plasma levels in EOC and benign samples were compared using a two-tailed Chi2 or Fisher's exact test. The associations of the analytes and Kyn/Trp with clinicopathological parameters, platinum-sensitivity, and the presence of CTC-related transcripts were assessed using a two-sided t-test. Associations with patient outcome were evaluated using Cox regression analysis. RESULTS: In EOC, elevated Kyn/Trp and neopterin levels were associated with advanced disease, peritoneal carcinomatosis, ascites, sub-optimal debulking, poor response to therapy and worse outcome. Likewise, neopterin and Kyn/Trp were elevated in CTC-positive patients, both at diagnosis and at follow-up in platinum-sensitive disease. CONCLUSIONS: We observed concomitant alterations of CTCs and immune system related biomarkers suggesting that immune responses along with increase of neopterin and Kyn/Trp concentrations are not necessarily only located at the site of the tumor, but may also go on in the circulation.
引用
- Gostner JM, Obermayr E, Braicu IE, et al. Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortium. Gynecol Oncol. 2018. PMID: 29530331. doi:10.1016/j.ygyno.2018.02.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。